Motivation and aim
The prevalence of neurological disorders has reached alarming levels, with nearly one in three individuals experiencing such conditions in their lifetime. Over the past three decades, global mortality rates related to neurological disorders have surged by 39%, while Disability-Adjusted Life Years (DALYs) have increased by 15%. These disorders now stand as the second leading cause of death and the leading cause of DALYs. The current preventive and management measures in place are insufficient, necessitating the development of new strategies to alleviate this growing burden.
The RELIEVE project addresses this urgent need by pioneering the development of a groundbreaking non-invasive closed-loop monitoring and intervention system for brain-related disorders. This innovative approach holds promise for the effective treatment and management of various psychiatric and neurological conditions. Our initial focus lies on epilepsy, a widespread neurological disorder affecting an estimated 70 million people worldwide. By leveraging our technology, we aim to make substantial advancements in epilepsy care and subsequently expand our efforts to other related disorders.
Project facts
Name: RELIEVE
Duration: April 2023 – April 2026
Consortium: 9 partners from 6 countries
Key areas: Medical devices, neurology, AI, closed-loop systems
Contact us
For inquiries about science and technology:
Alpha Brain Technologies
Avenue Ceramique 221, 6221 KX Maastricht, The Netherlands
relieve@alphabrain.tech
For all other inquiries:
Masaryk University
Bldg. E35/134 Kamenice, 753/5 625 00 Brno, Czechia
(+420) 549 49 7320
michaela.musilova@ceitec.muni.cz
